The Imaging, Psychopathology, Cognition and Therapeutics (IMPACT) program is engaged in a broad range of studies investigating brain structure, function, chemistry, and physiology related to cognition and mood in healthy individuals and in those with psychiatric and medical disorders. The IMPACT program seeks to develop and evaluate new treatments for people with disorders of cognition and mood . The program also provides learning opportunities for clinical neuroscience research.